未登录.png)
分享.png)
收藏分享 收藏 A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)
Takeuchi, S.; Sugawara, S.; Teramukai, S.; Noro, R.; Fujikawa, K.; Hirose, T.; Atagi, S.; Minami, S.; Iida, S.; Kuraishi, H.; Aiba, T.; Kawahara, M.; Minegishi, Y.; Matsumoto, M.; Seike, M.; Gemma, A.; Kubota, K. 分享 收藏 Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialSaito, H.; Yoshizawa, H.; Yoshimori, K.; Katakami, N.; Katsumata, N.; Kawahara, M.; Eguchi, K. 分享 收藏 Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer氨柔比星和顺铂在先前未经治疗的广泛期小细胞肺癌患者中的i-ii期研究Ohe, Y; Negoro, S; Matsui, K; Nakagawa, K; Sugiura, T; Takada, Y; Nishiwaki, Y; Yokota, S; Kawahara, M; Saijo, N; Fukuoka, M; Ariyoshi, Y 分享 收藏 Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02)Hosoe, S; Komuta, K; Shibata, K; Harada, H; Iwamoto, Y; Ohsaki, Y; Morioka, T; Origasa, H; Fukushima, M; Furuse, K; Kawahara, M 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
